Micronized Progesterone in Menopause: Uterine Protection, Sleep, Dosing and Safety

Micronized progesterone is a hormone that is chemically identical to the progesterone your ovaries make. The word micronized means the hormone is ground into very small particles so your body can absorb it when swallowed. In the U.S., the best-known brand is Prometrium, and generic capsules are also available.

Most women take it for one main reason: to protect the uterus. Estrogen makes the endometrium (the lining of the uterus) grow. When estrogen is taken alone, that growth can become excessive, called endometrial hyperplasia, and over time it can raise the risk of endometrial cancer. Progesterone balances this by shedding or thinning the lining. This is why women with a uterus who use systemic estrogen (pills, patches, gels or sprays) need a progestogen as well.

Women without a uterus, for example after a hysterectomy, usually do not need one for uterine protection. Women using only low-dose vaginal estrogen for local symptoms generally do not need one either, as absorption into the bloodstream is low.

People sometimes call progesterone "bioidentical," and micronized progesterone does match the body's own molecule. That is different from the custom-compounded mixtures marketed under the same word. Our article on [bioidentical versus synthetic HRT](/blog/bioidentical-vs-synthetic-hrt-what-the-research-shows) separates what is regulated and tested from what is not.

Progesterone protects the uterus very well when it is taken at the right dose and schedule. The key evidence is the PEPI trial (Postmenopausal Estrogen/Progestin Interventions), published in JAMA in 1995. It followed 875 postmenopausal women for three years.

Among women taking estrogen alone, 34% developed adenomatous or atypical hyperplasia. In the groups that added micronized progesterone, either continuous or on a cyclic schedule, the rate dropped to about 1%. That is a large difference, and it is the reason guidelines call for a progestogen with estrogen in women who have a uterus.

The lesson is not that estrogen is dangerous. It is that estrogen alone in a woman with a uterus is not safe long-term, while estrogen plus a progestogen is. Estrogen plus progesterone is a standard, well-studied regimen.

Timing also matters. For protection, progesterone needs to be taken for enough days: usually every day with continuous estrogen, or 12 to 14 days per month with cyclic regimens. Skipping doses or taking it only occasionally can leave the lining unprotected.

If you have started estrogen and are not sure about your progesterone plan, ask your clinician before your next refill. For the bigger picture on when to start, see [the HRT window of opportunity](/blog/the-hrt-window-of-opportunity-why-timing-matters).

Progesterone may help some women sleep, but the evidence comes from smaller studies, so it is not a guaranteed sleep aid. When you swallow it, your liver converts part of it into allopregnanolone, a compound that acts on GABA-A receptors, the same calming system targeted by some sleep medicines. That is why the capsule often causes drowsiness and why it is usually taken at bedtime.

In a small randomized trial by Schüssler and colleagues (Psychoneuroendocrinology, 2008), healthy postmenopausal women taking 300 mg of micronized progesterone at night showed improvements in sleep measures compared with placebo. Larger trials are limited, and results vary between people. Some women sleep deeply, some feel groggy the next morning, and some feel nothing.

If progesterone makes you feel foggy, dizzy or low in the morning, tell your clinician. Options include a lower dose, a different schedule or another progestogen. Never drive after a dose until you know how it affects you.

For persistent insomnia, progesterone is only one tool. Cognitive behavioral therapy for insomnia (CBT-I) has strong evidence and works without medication. See [CBT-I for menopause insomnia](/blog/cbt-i-for-menopause-insomnia-sleep-without-pills) for how it works. Night sweats can also be a hidden cause, so treating those may help sleep most.

In short, progesterone's sleep benefit is a possible bonus, not the main reason to take it.

A typical dose of micronized progesterone is 100 mg nightly with continuous estrogen, or 200 mg nightly for 12 to 14 days of each month with cyclic regimens. These doses follow guidance from groups such as The Menopause Society and match what was studied in trials like PEPI. Your clinician may adjust based on your symptoms, bleeding pattern and stage of menopause.

Continuous regimens use estrogen and progesterone every day. Many women stop bleeding after several months. Cyclic regimens use progesterone for part of the month and usually cause a monthly withdrawal bleed, which can be helpful in perimenopause when periods are still happening.

Take the capsule at bedtime, ideally on an empty stomach or a light stomach, since food can increase absorption and sedation. Do not crush or chew it. Some clinicians prescribe vaginal use off-label, but that is a different route with different absorption, so follow your own plan.

One ingredient detail is important: standard capsules are made with peanut oil. Women with a peanut allergy should not take them without clear medical guidance.

If you also use a GLP-1 medicine, you may wonder whether oral hormones are absorbed normally. Our article on [GLP-1 and HRT absorption](/blog/glp1-and-hrt-absorption-does-your-hormone-therapy-still-work) covers what is known, and your clinician can adjust the plan if symptoms change.

Micronized progesterone appears to carry less breast risk than some synthetic progestins, though the data come mostly from observational studies. In the Women's Health Initiative (WHI), estrogen plus the synthetic progestin medroxyprogesterone acetate (MPA) was linked to a higher breast cancer risk with longer use, while estrogen alone was not. The WHI did not study micronized progesterone.

The French E3N cohort (Fournier and colleagues, 2008) followed over 50,000 women and found no increase in breast cancer risk with estrogen plus micronized progesterone for up to a few years, while estrogen with synthetic progestins did show higher risk. Because it was an observational study, it cannot prove cause and effect, and larger randomized trials are lacking.

For blood clots, the delivery of estrogen matters more than the progesterone. Transdermal estrogen (patch or gel) is associated with a lower clot risk than oral estrogen. See [HRT and blood clot risk](/blog/hrt-and-blood-clot-risk-does-delivery-method-matter) for the details. For women with migraine, our guide to [HRT and migraine with aura](/blog/hrt-and-migraine-with-aura-is-it-safe) explains how to choose carefully.

In short, micronized progesterone is considered the preferred progestogen for many women, but your own risk factors, family history and screening schedule still matter. Regular mammograms and clinical check-ups continue as usual.

The most common side effects of micronized progesterone are drowsiness, dizziness, breast tenderness, bloating and mood changes. Most are mild and improve over a few weeks, and bedtime dosing helps with sleepiness.

Bleeding is the big one to watch. Spotting can be normal during the first three to six months of a continuous plan, and a scheduled bleed is expected on a cyclic plan. But heavy bleeding, bleeding that starts after months of none, or bleeding that continues beyond what your clinician described should be checked. Our article on [unscheduled bleeding on HRT](/blog/unscheduled-bleeding-on-hrt-when-to-worry-and-what-gets-checked) explains what evaluation usually involves.

Some women notice mood changes with progesterone, including feeling flat, irritable or low. If this happens, tell your clinician rather than quitting alone. Lowering the dose, shifting to a cyclic schedule or trying a different progestogen may help.

Get urgent care for signs of a serious reaction, such as swelling of the face or throat, trouble breathing, severe leg pain or swelling, chest pain, sudden vision changes or a severe headache. These are rare, but they need prompt attention.

This article is educational and not a substitute for medical advice. Your clinician should decide which hormone regimen fits your health history.

HRT decisions are personal, and a good plan starts with the right questions. Lea can help you understand your options and prepare for your appointment.